Summary of characteristics of PNH patients who should be considered for primary warfarin prophylaxis
1 | Granulocyte clone size larger than 50% |
| 2 | Platelet count stable at higher than 100 × 109/L |
| 3 | No known contraindication to anticoagulation |
| 4 | The possibility that thrombotic risk may change with time should be taken into consideration |
1 | Granulocyte clone size larger than 50% |
| 2 | Platelet count stable at higher than 100 × 109/L |
| 3 | No known contraindication to anticoagulation |
| 4 | The possibility that thrombotic risk may change with time should be taken into consideration |